Search research articles
Contact Us
Filters
Showing results (11-20 of 179) with videos related to
Page
of 18
Sort By:
Journal of Inorganic Biochemistry
|
March 6, 2012
Is DTPA a good competing chelating agent for Th(IV) in human serum and suitable in targeted alpha therapy?
Alicia Le Du, Andrea Sabatié-Gogova, Alfred Morgenstern, et al.
Journal of Inorganic Biochemistry
|
October 6, 2009
Spectroscopic study of the interaction of U(VI) with transferrin and albumin for speciation of U(VI) under blood serum conditions
Gilles Montavon, Christos Apostolidis, Frank Bruchertseifer, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology
|
December 6, 2013
Functionalized NaA nanozeolites labeled with <sup>224,225</sup>Ra for targeted alpha therapy
Agata Piotrowska, Edyta Leszczuk, Frank Bruchertseifer, et al.
Molecular Pharmaceutics
|
March 6, 2018
Evaluation of an Anti-HER2 Nanobody Labeled with <sup>225</sup>Ac for Targeted α-Particle Therapy of Cancer
Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, et al.
Frontiers in Medicine
|
January 2, 2023
Targeted alpha therapy for glioblastoma
Jolanta Kunikowska, Alfred Morgenstern, Kacper Pełka, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
March 3, 2021
Radiochemical separation of <sup>224</sup>Ra from <sup>232</sup>U and <sup>228</sup>Th sources for <sup>224</sup>Ra/<sup>212</sup>Pb/<sup>212</sup>Bi generator
Marek Pruszyński, Rafał Walczak, Magdalena Rodak, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 26, 2021
Global experience with PSMA-based alpha therapy in prostate cancer
Mike M Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Current Opinion in Urology
|
October 24, 2019
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer
Ismaheel O Lawal, Frank Bruchertseifer, Mariza Vorster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2021
Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer
Mike M Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Cancer Research
|
July 24, 2010
Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer
Mohanambe Lingappa, Hong Song, Sarah Thompson, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 179) with videos related to
Sort By:
Page
of 18
Journal of Inorganic Biochemistry
|
March 6, 2012
Is DTPA a good competing chelating agent for Th(IV) in human serum and suitable in targeted alpha therapy?
Alicia Le Du, Andrea Sabatié-Gogova, Alfred Morgenstern, et al.
Journal of Inorganic Biochemistry
|
October 6, 2009
Spectroscopic study of the interaction of U(VI) with transferrin and albumin for speciation of U(VI) under blood serum conditions
Gilles Montavon, Christos Apostolidis, Frank Bruchertseifer, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology
|
December 6, 2013
Functionalized NaA nanozeolites labeled with <sup>224,225</sup>Ra for targeted alpha therapy
Agata Piotrowska, Edyta Leszczuk, Frank Bruchertseifer, et al.
Molecular Pharmaceutics
|
March 6, 2018
Evaluation of an Anti-HER2 Nanobody Labeled with <sup>225</sup>Ac for Targeted α-Particle Therapy of Cancer
Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, et al.
Frontiers in Medicine
|
January 2, 2023
Targeted alpha therapy for glioblastoma
Jolanta Kunikowska, Alfred Morgenstern, Kacper Pełka, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
March 3, 2021
Radiochemical separation of <sup>224</sup>Ra from <sup>232</sup>U and <sup>228</sup>Th sources for <sup>224</sup>Ra/<sup>212</sup>Pb/<sup>212</sup>Bi generator
Marek Pruszyński, Rafał Walczak, Magdalena Rodak, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 26, 2021
Global experience with PSMA-based alpha therapy in prostate cancer
Mike M Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Current Opinion in Urology
|
October 24, 2019
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer
Ismaheel O Lawal, Frank Bruchertseifer, Mariza Vorster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2021
Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer
Mike M Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Cancer Research
|
July 24, 2010
Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer
Mohanambe Lingappa, Hong Song, Sarah Thompson, et al.
Page
of 18